Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study

Published:2020-02-12 Issue:9 Volume:16 Page:2265-2273
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Romanenko Victor¹,Osipova Irina²,Galustyan Anna³,Scherbakov Michael⁴^ORCID,Baudson Nathalie⁵,Farhi Déborah⁶,Anaya Luis⁶,Kuriyakose Sherine O.⁷,Meyer Nadia⁶^ORCID,Janssens Winnie⁶^ORCID

Affiliation:

1. Children’s City Hospital №11, Ekaterinburg, Russian Federation

2. OOO “ASKO-MED-PLUS”, Barnaul, Russian Federation

3. Medical Technologies Ltd, St. Petersburg, Russian Federation

4. GSK, Moscow, Russian Federation

5. GSK, Rixensart, Belgium

6. GSK, Wavre, Belgium

7. GSK Asia Private Ltd., Bengaluru, India

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1720437

Reference43 articles.

1. Pediatric disease burden and vaccination recommendations: understanding local differences

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and factors associated with pentavalent vaccination: a cross-sectional study in Southern China;Infectious Diseases of Poverty;2023-09-15

2. Combination Vaccines;Plotkin's Vaccines;2023

3. Cost‐minimization analysis of DTaP‐IPV‐Hib combination vaccine in China: A nationwide cross‐sectional study;Journal of Medical Virology;2022-12-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3